Dr. Smith earned his A.B. in Chemistry at Harvard College and pursued his MD and PhD at the University of California, San Francisco. He returned to Boston for Pediatrics Residency...
Dr. David Shulman studies novel therapies and biomarkers for advanced pediatric solid tumors within the Dana-Farber Experimental Therapeutics Program. In addition to early phase clinical trials, Dr. Shulman also studies...
Dr. Sue Morris is a senior psychologist and Director of Bereavement Services at Dana-Farber Cancer Institute in Boston. She is also a member of Robert's Program on Sudden Unexpected Death...
I am an attending pediatric oncologist and physician scientist interested in the discovery and design of new therapeutic agents for pediatric cancers.